You searched for: issuspettati (Maltesiska - Engelska)

interrazzjonijiet issuspettati
suspected interactions

rapportar ta’ reazzjonijiet avversi issuspettati
reporting of suspected adverse reactions

li huma misjuba jew issuspettati f'ċerti setturi produttivi;
detected or suspected in certain product sectors;

irraportar ta’ reazzjonijiet avverssi issuspettati wara awtorizazzjoni tal-prodott mediċinali huwa importanti.
reporting suspected adverse reactions after authorisation of the medicinal product is important.

professjonisti fill-kura tas-saħħa huma mitluba biex jirraportaw kull tip ta reazzjonijiet avversi issuspettati.
healthcare professionals are asked to report any suspected adverse reactions.

għalhekk, palifermin m’għandux jingħata lil pazjenti b’tumuri malinni mhux ematoloġiċi magħrufa jew issuspettati.
palifermin should therefore not be given to patients with known or suspected non-haematological malignancies.

konsiderazzjoni għandha tingħata għal waqfien tat-trattament b’tigecycline f’każijiet issuspettati li żviluppaw pankreatite.
consideration should be given to the cessation of the treatment with tigecycline in cases suspected of having developed pancreatitis.

annimali morda jew issuspettati m'għandhomx jinqatlu fl-istabbiliment ikkonċernat ħlief meta tingħata deroga mill-awtorità kompetenti.
sick or suspect animals must not be slaughtered in the establishment concerned except where a derogation is granted by the competent authority.

persuni magħrufa lill-awtorità li tagħmel it-talba li jkunu wettqu ksur tal-leġislazzjoni doganali jew issuspettati li għamlu dan;
persons known to the requesting authority to have committed a breach of customs legislation or suspected of doing so;

ir-riskji u l-benefiċċji terapewtiċi għandhom ikunu evalwati b’attenzjoni f’pazjenti b’infezzjonijiet attivi jew issuspettati.
therapeutic risks and benefits should be carefully evaluated in patients with active or suspected infections.

iżda, ċerti lakuni leġislattivi mhux issuspettati, nuqqas ta » ċarezza, komplikazzjonijiet jew ostakoli jistgħu jimpedixxu riżultat legali sod, ta » lanqas fi żmien raġonevoli.
however, certain previously unsuspected legislative gaps, lack of clarity, complications or barriers may impede a sound legal result, at least within a reasonable time.

il-pazjenti magħrufin jew issuspettati li mhumiex metabolizzaturi daqstant tajbin ta’ cyp2c9 fuq il- bażi tal-istorja/esperjenza preċedenti b’substrati oħra ta’ cyp2c9 għandhom jingħataw celecoxib b’kawtela (ara sezzjoni 4.2).
patients who are known or suspected to be cyp2c9 poor metabolizers based on previous history/experience with other cyp2c9 substrates should be administered celecoxib with caution (see section 4.2).